Generative Phosphoproteomics AP3 platform designed to enable streamlined, rational drug discovery, with proprietary, proteome ...

Evolution in women's cancer diagnostics: from histopathology to molecular testing, personalized treatment for breast, ovarian ...

A comparison of patients with and without BRCA gene mutations receiving prophylactic risk-reduction surgery suggest ...

We are pleased to welcome Preetam to Elicio’s executive team,” said Robert Connelly, Ph.D., President and Chief Executive Officer of Elicio. “He joins us during an exciting time. We remain encouraged ...

Microbial Signature of Colorectal Cancer-Associated Mutations Identified in New Study Apr. 4, 2024 — Researchers have connected KRAS mutations in colorectal cancer to microbial signatures in the ...

Wojciech Jurczak, MD, PhD, discusses advancements in B-cell lymphoma therapy, focusing on immunotherapy, molecular-targeted agents, and more.

European regulators have cleared Anocca to begin a Phase I/II umbrella trial of its lead targeted T-cell receptor (TCR) therapy ANOC-001 and other pipeline candidates in certain advanced pancreatic ...

In this interview, Dr. Christian Schafmeister discusses the structural advantages of Spiroligomer molecules, their ability to ...

本研究构建了含p53错义突变的膀胱癌小鼠模型，发现PTEN缺失促使p53野生型等位基因丢失，驱动肿瘤发生和免疫逃逸，该模型能模拟人基底-鳞状亚型 ...

The DREAM repressor complex regulates genes involved in the cell cycle and DNA repair, vital for maintaining genome stability. Although it mediates p53-driven repression through the canonical ...